164 related articles for article (PubMed ID: 37747668)
1. Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study.
Zheng C; Gu XT; Huang XL; Wei YC; Chen L; Luo NB; Lin HS; Jin-Yuan L
Radiol Med; 2023 Dec; 128(12):1460-1471. PubMed ID: 37747668
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Tang YY; Zhao YN; Zhang T; Chen ZY; Ma XL
World J Gastroenterol; 2021 Nov; 27(41):7173-7189. PubMed ID: 34887636
[TBL] [Abstract][Full Text] [Related]
3. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data.
Zhang J; Dong W; Li Y; Fu J; Jia N
Eur J Radiol; 2023 Jun; 163():110839. PubMed ID: 37121101
[TBL] [Abstract][Full Text] [Related]
4. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
5. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
6. Preoperative evaluation of MRI features and inflammatory biomarkers in predicting microvascular invasion of combined hepatocellular cholangiocarcinoma.
Zhang J; Dong W; Liu W; Fu J; Liao T; Li Y; Huo L; Jia N
Abdom Radiol (NY); 2024 Mar; 49(3):710-721. PubMed ID: 38112787
[TBL] [Abstract][Full Text] [Related]
7. Letter to the editor Re "Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study".
Xie Y; Wang J; Zou Y
Radiol Med; 2024 Apr; 129(4):665-666. PubMed ID: 38512607
[No Abstract] [Full Text] [Related]
8. Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study.
Wu Y; Liu H; Zeng J; Chen Y; Fang G; Zhang J; Zhou W; Zeng Y; Liu J
World J Surg Oncol; 2022 Feb; 20(1):60. PubMed ID: 35227269
[TBL] [Abstract][Full Text] [Related]
9. Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection.
Wang T; Yang X; Tang H; Kong J; Shen S; Qiu H; Wang W
Aging (Albany NY); 2020 Aug; 12(15):15334-15358. PubMed ID: 32788423
[TBL] [Abstract][Full Text] [Related]
10. Letter to Dr. Wang Jian and his team about our paper "Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study" published on "La radiologia medica".
Liao JY
Radiol Med; 2024 Apr; 129(4):667. PubMed ID: 38512610
[No Abstract] [Full Text] [Related]
11. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma.
Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
Abdom Radiol (NY); 2024 Feb; 49(2):425-436. PubMed ID: 37889266
[TBL] [Abstract][Full Text] [Related]
12. A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma.
Wang Y; Zhou CW; Zhu GQ; Li N; Qian XL; Chong HH; Yang C; Zeng MS
Ann Transl Med; 2021 Oct; 9(20):1518. PubMed ID: 34790724
[TBL] [Abstract][Full Text] [Related]
13. Contrast-Enhanced Ultrasound-Based Nomogram: A Potential Predictor of Individually Postoperative Early Recurrence for Patients With Combined Hepatocellular-Cholangiocarcinoma.
Guo HL; Lu XZ; Hu HT; Ruan SM; Zheng X; Xie XY; Lu MD; Kuang M; Shen SL; Chen LD; Wang W
J Ultrasound Med; 2022 Aug; 41(8):1925-1938. PubMed ID: 34751450
[TBL] [Abstract][Full Text] [Related]
14. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC
Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837
[TBL] [Abstract][Full Text] [Related]
15. Radiomics nomogram based on optimal VOI of multi-sequence MRI for predicting microvascular invasion in intrahepatic cholangiocarcinoma.
Ma X; Qian X; Wang Q; Zhang Y; Zong R; Zhang J; Qian B; Yang C; Lu X; Shi Y
Radiol Med; 2023 Nov; 128(11):1296-1309. PubMed ID: 37679641
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images.
Chen S; Wan L; Zhao R; Peng W; Li Z; Zou S; Zhang H
Abdom Radiol (NY); 2023 Apr; 48(4):1306-1319. PubMed ID: 36872324
[TBL] [Abstract][Full Text] [Related]
17. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
18. Nomogram based on MRI for preoperative prediction of Ki-67 expression in patients with intrahepatic mass cholangiocarcinoma.
Chen X; Zhu J; Zou Z; Du M; Xie J; Ye Y; Zhang L; Li Y
Abdom Radiol (NY); 2023 Feb; 48(2):567-578. PubMed ID: 36401626
[TBL] [Abstract][Full Text] [Related]
19. The potential of
Jiang S; Gao X; Tian Y; Chen J; Wang Y; Jiang Y; He Y
Abdom Radiol (NY); 2024 May; 49(5):1444-1455. PubMed ID: 38265452
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma.
Huang X; Li Y; Long L
Med Sci Monit; 2019 Nov; 25():8595-8601. PubMed ID: 31726461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
